DNA strands in materials act like traffic signals to start, stop cell activity or regenerate tissue
A groundbreaking advancement in materials from Northwestern University could potentially help patients requiring stem cell therapies for spinal cord injuries, stroke, Parkinson’s disease, Alzheimer’s disease, arthritic joints or any other condition requiring tissue regeneration, according to a new study.
“It’s important in the context of cell therapies for people to cure these diseases or regenerate tissues that are no longer functional,” said senior author Samuel I. Stupp, director of Northwestern’s Simpson Querrey Institute for BioNanotechnology and Board of Trustees Professor of Materials Science and Engineering, Chemistry, Medicine and Biomedical Engineering.
Cells in our bodies are constantly being signaled with many types of instructions coming from proteins and other molecules present in the matrices that surround them. For example, these can be cues for cells to express specific genes so they can proliferate or differentiate into several types of cells leading to growth or regeneration of tissues. One of the marvels of this signaling machinery is the built-in capacity in living organisms to make signals stop and re-start as needed, or to switch off one signal and activate a different one to orchestrate very complex processes. Building artificial materials with this type of dynamic capacity for regenerative therapies has been virtually impossible so far.
New technology could be useful in therapies using patient-derived stem cells to regenerate tissue
The new work published today reports the development of the first synthetic material that has the capability to trigger reversibly this type of dynamic signaling. The platform could not only lead to materials that manage stem cells for more effective regenerative therapies, but will also allow scientists to explore and discover in the laboratory new ways to control the fate of cells and their functions.
One of the findings is the possibility of using the synthetic material to signal neural stem cells to proliferate, then at a specific time selected by the operator, trigger their differentiation into neurons and then return the stem cells back to a proliferative state on demand.
The paper also reports that spinal cord neural stem cells, initially grouped into structures known as “neurospheres,” can be driven to spread out and differentiate using a signal. But when this signal is switched off, the cells spontaneously re-group themselves into colonies. This uncovers strong interactions among these cells that could be important in understanding developmental and regenerative cues.
Stem cell proliferation and differentiation can be triggered over multiple cycles with new materials technology
The potential use of the new technology to manipulate cells could help cure a patient with Parkinson’s disease. The patient’s own skin cells could be converted to stem cells using existing techniques. The new technology could help expand the newly converted stem cells in vitro – in the lab – and then drive their differentiation into dopamine-producing neurons before transplantation back to the patient.
In the new technology, materials are chemically decorated with different strands of DNA, each designed to display a different signal to cells. To activate signals to cells, soluble molecules containing complementary DNA strands coupled to peptides are added to the material to create DNA double helices displaying the signal. By adding a few drops of the DNA-peptide conjugate, a green light is given to produce more stem cells. The approach to provide the material with dynamic intelligence is to expose the surface to a soluble single-stranded DNA molecule designed to “grab” the signal-containing strand of the duplex and form a new DNA double helix. This new duplex is no longer attached to the material surface and washes away, thus switching the biological signal off. To turn the signal back on, all that is needed is to now introduce a new copy of single-stranded DNA bearing a signal that will reattach to the material’s surface.
“People would love to have cell therapies that utilize stem cells derived from their own bodies to regenerate tissue,” Stupp said. “In principle, this will eventually be possible, but one needs procedures that are effective at expanding and differentiating cells in order to do so. Our technology does that.”
Starting or stopping cell activity existed before; this research discovered how to re-start and stop again cell activity several times
While this process is currently only done in vitro with the vision of then transplanting cells, Stupp said in the future it might be possible to perform this process in vivo. The stem cells would be implanted in the clinic, encapsulated in the type of material described in the new work, via an injection and targeted to a particular spot. Then the soluble molecules would be given to the patient to manipulate proliferation and differentiation of transplanted cells.
The Latest on: Tissue regeneration
- New in vivo priming strategy to train stem cells can enhance cardiac repair effectivenesson March 27, 2020 at 11:14 am
Human stem cells have been regarded as one of the promising cell sources for cardiac regeneration therapy. But their clinical use is hampered due ... by 3D-printing of pig heart-derived extracellular ...
- Model that sheds light on severe Duchenne muscular dystrophy could pave the way for new therapieson March 26, 2020 at 7:41 am
This leads to muscle degeneration, chronic inflammation, weakness and a poor ability to regenerate any muscle tissue that has been lost. Symptoms emerge early on in childhood and start with weaknesses ...
- Experimental model mimics early-stage myogenic deficit in boys with DMDon March 26, 2020 at 6:01 am
An experimental model of severe DMD that experiences a large spike in transforming growth factor-beta (TGFβ) activity after muscle injury shows that high TGFβ activity suppresses muscle regeneration ...
- Cell reprogramming using extracellular vesicles from differentiating stem cells into white/beige adipocyteson March 25, 2020 at 12:14 pm
and placental tissue are widely clinically used as therapeutic agents for tissue repair and regeneration (1, 2). Human adipose-derived stem cells (HASCs) are the most often used MSCs because of the ...
- Regenerative Medicine Market Size and Forecast To 2026on March 25, 2020 at 5:02 am
Regenerative Medicine Market Analysis According to Verified Market Research, the Global Regenerative Medicine Market ...
- Nerves are a lifeline for growing cancerson March 24, 2020 at 7:18 am
Different stem cell populations connect to nerves in distinct ways, new research shows. Innervation may therefore be crucial for proper tissue regeneration, researchers report. In their new work, the ...
- Interference with SRF expression in skeletal muscles reduces peripheral nerve regeneration in miceon March 24, 2020 at 3:39 am
Traumatic injury of peripheral nerves typically also damages nerve surrounding tissue including muscles. Hence, molecular and cellular interactions of neighboring damaged tissues might be decisive for ...
- Stem cells and nerves interact in tissue regeneration and cancer progressionon March 23, 2020 at 8:42 am
However, little is known about the interactions between stem cells and neurons in regenerating tissues and in cancers. Comparing stem cell types in tissue regeneration A team of researchers led by ...
- Stem cells establish contacts with nerves in tissue regeneration and cancer progressionon March 23, 2020 at 5:13 am
Researchers at the University of Zurich show that different stem cell populations are innervated in distinct ways. Innervation may therefore be crucial for proper tissue regeneration. They also ...
- 3D printing of Haversian bone–mimicking scaffolds for multicellular delivery in bone regenerationon March 20, 2020 at 12:15 pm
The work offers a new strategy for designing structured and functionalized biomaterials through mimicking native complex bone tissue for tissue regeneration. Bone tissue is an indispensable part of ...
via Google News and Bing News